Celgene Corporation (CELG) is the US biotech company that specializes in the discovery, production and marketing of medicines for cancer treatment and inflammatory diseases. The company’s flagship product is Revlimid, a medicine designed to treat myeloma. Apart from Revlimid, Celgene has a portfolio of products to offer including Vidaza, OTEZLA, ISTODAX and others. Most products developed by the Celgene Corporation consist of ImiDs compounds that boast highly important properties. Celgene Corp is listed on the NASDAQ stock exchange and constitutes the NASDAQ-100 index.